BioLineRx Ltd. Finance Costs
BioLineRx Ltd. (BLRX) reported Finance Costs of $1.28 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-23
- BioLineRx Ltd. finance costs for the quarter ending 2025-06-30 was $276.00K, a 86.76% decline year-over-year.
- BioLineRx Ltd. finance costs for the quarter ending 2024-06-30 was $2.08M, a 55.95% increase year-over-year.
- BioLineRx Ltd. finance costs for the quarter ending 2023-06-30 was $1.34M, a 252.77% increase year-over-year.
- BioLineRx Ltd. finance costs for the quarter ending 2022-06-30 was $379.00K, a 56.61% increase year-over-year.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 12 month |
|---|---|---|---|
| 2025-12-31 | $1.28M 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $276.00K 6-K · filed 2025-08-14 | $696.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $9.12M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $2.08M 6-K · filed 2025-08-14 | $3.01M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $2.17M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $1.34M 6-K · filed 2024-08-15 | $2.26M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $2.16M 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $379.00K 6-K · filed 2023-08-30 | $565.00K 6-K · filed 2023-08-30 | |
| 2021-12-31 | $1.01M 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $242.00K 6-K · filed 2022-08-16 | $541.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | $1.63M 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $396.00K 6-K · filed 2021-08-18 | $810.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | $2.28M 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $440.00K 6-K · filed 2020-08-06 | $887.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $473.00K 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $11.00K 6-K · filed 2019-08-06 | $217.00K 6-K · filed 2019-08-06 | |
| 2017-12-31 | $21.00K 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $3.00K 6-K · filed 2018-08-13 | $9.00K 6-K · filed 2018-08-13 | |
| 2016-12-31 | $22.00K 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $106.00K 20-F · filed 2018-03-06 |